Health ThermoGenesis Holdings to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide a Corporate Strategic Update August 10, 2022
Health Biora Therapeutics Announces Successful Completion of Device Performance Study in Ulcerative Colitis Patients for its Targeted Therapeutics Platform August 10, 2022
Health Traders News Source Senior Editor, Mark Roberts Interviews Evofem Biosciences, Inc. CEO Saundra Pelletier August 10, 2022
Health Outlook Therapeutics Reports Financial Results for Third Quarter Fiscal Year 2022 and Reiterates Key Anticipated Near-Term Milestones August 10, 2022
Health Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination August 9, 2022
Health Evofem Announces Completion of Last Subject Last Visit (LSLV) in Registrational Phase 3 “EVOGUARD” Trial Evaluating Phexxi® for the Prevention of Chlamydia and Gonorrhea in Women August 9, 2022
Search
Health
August 10, 2022
August 10, 2022
August 10, 2022
August 10, 2022
August 10, 2022
August 10, 2022
August 10, 2022
August 9, 2022
August 9, 2022
August 9, 2022
